|
[Related PubMed/MEDLINE]
Total Number of Papers: 21
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: LCNPs |
| Long Form |
: liquid crystalline nanoparticles |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2019 |
Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells. |
CTAB, GMO, NSCLC, PMX, RSV, SCLC |
| 2 |
2019 |
Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management. |
Brb-OL, Brb-OL-LCNPs |
| 3 |
2019 |
Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine. |
LLC |
| 4 |
2018 |
Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide. |
cryo-TEM, DLS, SAXS |
| 5 |
2018 |
Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy. |
INS, QT |
| 6 |
2018 |
Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement. |
AmB, GMO, PT |
| 7 |
2018 |
Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. |
GMO |
| 8 |
2017 |
"Liquid Crystalline Nanoparticles": Rationally Designed Vehicle To Improve Stability and Therapeutic Efficacy of Insulin Following Oral Administration. |
--- |
| 9 |
2016 |
Interfacial properties of POPC/GDO liquid crystalline nanoparticles deposited on anionic and cationic silica surfaces. |
--- |
| 10 |
2016 |
Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation. |
Tet, TET-LCNPs |
| 11 |
2016 |
Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. |
GMO, TEM |
| 12 |
2016 |
Thermomyces lanuginosus lipase-catalyzed hydrolysis of the lipid cubic liquid crystalline nanoparticles. |
GMO |
| 13 |
2014 |
Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. |
--- |
| 14 |
2014 |
Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships. |
IVIVR, PDI |
| 15 |
2013 |
A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. |
GMO, IOP, PN, TEM |
| 16 |
2012 |
Adsorption of lipid liquid crystalline nanoparticles on cationic, hydrophilic, and hydrophobic surfaces. |
--- |
| 17 |
2012 |
Adsorption of lipid liquid crystalline nanoparticles: effects of particle composition, internal structure, and phase behavior. |
APTES, cryo-TEM, DLS, GDO, PEO, SAXS, SPC |
| 18 |
2012 |
Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption. |
--- |
| 19 |
2012 |
Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability. |
DSPE-PEG, LC, PTX |
| 20 |
2010 |
Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. |
DGMO, FRET, GDO, GMO, i.v, SPC |
| 21 |
2010 |
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model. |
--- |
|
A Search Service for Abbreviation / Long Form
